'Lansley must listen to nurses on the front line' NICE approves lung cancer drug
NICE has issued final guidance on the on the use of pemetrexed disodium (Alimta) for the treatment of malignant pleural mesothelioma, an asbestos-induced lung cancer.The institute recommend that the drug be made available on the NHS for all patients who are considered to have advanced disease, and for whom surgical intervention is not deemed appropriate.
You need to register to view this content
You now need to register for FREE to read our news. Please sign in or register to continue
- Registering is FREE and takes only two minutes
- Registering allows you to read our registered-only news, practice comments and access our Nursing Times Learning units.
- You'll also be able to sign up for our free newsletters
Already registered?
To check that you are registered please enter your email address below
Not registered?
Registration is free and takes just two minutes. After you register, you'll get access to our news stories, competitions and giveaways, newsletters and more.
Not activated?
If you are a registered subscriber you also need to activate your subscription in order to access your subscriber-only content online. This includes free learning units and practice articles.
